17 studies found for:    Sm-153
Show Display Options
Rank Status Study
1 Completed
Has Results
Samarium-153 With Neoadjuvant Hormonal and Radiation Therapy for Locally Advanced Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Samarium-153;   Drug: Total Androgen Suppression (TAS) with Bicalutamide;   Drug: Total androgen suppression (TAS) with Goserelin Acetate;   Device: Radiation Therapy
2 Active, not recruiting Samarium Sm 153 Lexidronam Pentasodium Combined With Zoledronic Acid or Pamidronate in Treating Patients With Relapsed or Refractory Multiple Myeloma and Bone Pain
Conditions: Multiple Myeloma and Plasma Cell Neoplasm;   Pain
Interventions: Drug: Pamidronate;   Drug: Zoledronic acid;   Radiation: Sm 153 lexidronam
3 Unknown  Study of Samarium Sm-153 Lexidronam Combined With Docetaxel for Patients With Prostate Cancer
Condition: Prostatic Neoplasms
Intervention: Drug: Samarium Sm-153 lexidronam + Docetaxel
4 Completed Samarium Sm 153 and Stem Cell Transplant Followed By Radiation Therapy Patients With Osteosarcoma
Condition: Sarcoma
Interventions: Biological: filgrastim;   Drug: ifosfamide;   Procedure: peripheral blood stem cell transplantation;   Radiation: radiation;   Radiation: samarium Sm 153 lexidronam pentasodium
5 Active, not recruiting Samarium Sm 153 Lexidronam Pentasodium and 3-Dimensional Conformal Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Rising Prostate-Specific Antigen Levels After Radical Prostatectomy for Prostate Cancer
Condition: Prostate Cancer
Interventions: Radiation: 3-dimensional conformal radiation therapy (3D-CRT);   Radiation: intensity-modulated radiation therapy (IMRT);   Radiation: samarium Sm 153 lexidronam pentasodium
6 Completed Sm-EDTMP and Autologous Peripheral Blood Stem Cell Transplantation for Breast Cancer Patients With Bone Only Metastases
Conditions: Breast Cancer;   Bone Metastases
Interventions: Drug: 153 Sm-EDTMP;   Behavioral: Questionnaire;   Procedure: Stem Cell Transplant
7 Recruiting Combination of External Beam Radiotherapy With 153Sm-EDTMP to Treat High Risk Osteosarcoma
Condition: Metastatic Osteosarcoma
Interventions: Drug: Sm-EDTMP;   Other: Autologous Stem Cell Infusion;   Radiation: External Beam Radiotherapy
8 Completed Samarium Sm 153 Lexidronam Pentasodium and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Interventions: Drug: bortezomib;   Other: immunologic technique;   Radiation: samarium Sm 153 lexidronam pentasodium
9 Active, not recruiting
Has Results
Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast Cancer
Conditions: Breast Cancer;   Lung Cancer;   Metastatic Cancer;   Pain;   Prostate Cancer
Interventions: Dietary Supplement: Calcium;   Dietary Supplement: Vitamin D;   Drug: zoledronic acid;   Drug: Sm-153;   Radiation: Sr-89
10 Completed Samarium 153 and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Interventions: Drug: bortezomib;   Radiation: samarium Sm 153 lexidronam pentasodium
11 Completed
Has Results
153Sm-EDTMP With or Without a PSA/TRICOM Vaccine To Treat Men With Androgen-Insensitive Prostate Cancer
Condition: Prostate Cancer
Interventions: Radiation: Samarium Sm 153 lexidronam pentasodium;   Biological: Sargramostim;   Biological: Recombinant vaccinia-TRICOM vaccine;   Biological: Recombinant fowlpox-TRICOM vaccine
12 Completed Study of Docetaxel +153 Sm-EDTMP in Patients With Hormone-Refractory Prostate Cancer
Condition: Prostate Cancer
Intervention: Drug: Docetaxel
13 Completed Samarium Sm 153 Lexidronam Pentasodium and High-Dose Melphalan in Treating Patients With Multiple Myeloma Undergoing Stem Cell Transplant
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Interventions: Biological: sargramostim;   Drug: melphalan;   Procedure: autologous hematopoietic stem cell transplantation;   Procedure: peripheral blood stem cell transplantation;   Radiation: samarium Sm 153 lexidronam pentasodium
14 Unknown  A Trial of Samarium 153 Followed by Salvage Prostatic Fossa 3D-CRT or IMRT Irradiation in High-Risk, Clinically Non-Metastatic Prostate Cancer After Radical Prostatectomy
Conditions: Non-metastatic Prostate Cancer;   Post Radical Prostatectomy
Interventions: Drug: Samarium/IMRT;   Drug: Samarium ethylenediaminetetramethylenephosphonate
15 Unknown  Repeated Bone Marrow Transplantation in Treating Women With Advanced Breast Cancer
Condition: Breast Cancer
Interventions: Biological: filgrastim;   Drug: CAF regimen;   Drug: carboplatin;   Drug: cisplatin;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: fluorouracil;   Drug: ifosfamide;   Drug: melphalan;   Drug: paclitaxel;   Drug: thiotepa;   Procedure: peripheral blood stem cell transplantation;   Radiation: samarium Sm 153 lexidronam pentasodium
16 Unknown  Effect of Samarium on the Relief of Pain Due to Vertebral Metastases
Conditions: Cancer;   Metastasis;   Pain
Intervention: Drug: Samarium (153SM)
17 Suspended Evaluation of the CardioSond Electronic Stethoscope in the Detection of Coronary Artery Disease
Condition: Coronary Artery Disease
Intervention:

Indicates status has not been verified in more than two years